Gene: UBR2
Official Full Name: ubiquitin protein ligase E3 component n-recognin 2provided by HGNC
Gene Summary: Enables L-leucine binding activity and ubiquitin protein ligase activity. Involved in several processes, including cellular response to L-leucine; protein K63-linked ubiquitination; and regulation of signal transduction. Predicted to be located in cytosol. Predicted to be part of ubiquitin ligase complex. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00349 | UBR2 Knockout cell line(293T) | Human | UBR2 | 1:3~1:6 | Negative | Online Inquiry |
KO29504 | UBR2 Knockout cell line (HeLa) | Human | UBR2 | 1:3~1:6 | Negative | Online Inquiry |
KO29505 | UBR2 Knockout cell line (HCT 116) | Human | UBR2 | 1:2~1:4 | Negative | Online Inquiry |
KO29506 | UBR2 Knockout cell line (HEK293) | Human | UBR2 | 1:3~1:6 | Negative | Online Inquiry |
KO29507 | UBR2 Knockout cell line (A549) | Human | UBR2 | 1:3~1:4 | Negative | Online Inquiry |
UBR2 Gene Knockout Cell Lines are genetically modified cell lines that have undergone targeted gene disruption of the UBR2 gene, which encodes a ubiquitin ligase involved in proteasome-mediated protein degradation. This innovative biological product allows researchers to study the functional consequences of UBR2 loss and its role in various cellular processes, including the regulation of cell cycle, apoptosis, and cellular stress responses.
The primary mechanism by which these knockout cell lines function is through the removal of the UBR2 gene, leading to alterations in protein homeostasis and signaling pathways that depend on ubiquitination. This disruption allows scientists to observe phenotypic changes and investigate the downstream effects on cellular behavior and pathophysiological conditions.
Scientifically, UBR2 Gene Knockout Cell Lines are invaluable in both research and clinical settings. They can be used to model diseases where UBR2 is implicated, such as certain cancers or neurodegenerative disorders, facilitating the discovery of potential therapeutic targets. Furthermore, they serve as tools for drug screening and validating the efficacy of novel compounds aimed at restoring normal cellular functions.
Compared to traditional cell lines or less specific gene knockout models, UBR2 Gene Knockout Cell Lines offer unparalleled specificity and reproducibility. By precisely targeting the UBR2 gene, these cell lines enable more accurate modeling of biological mechanisms and reduce the background noise associated with non-specific gene disruptions.
Researchers and clinicians can greatly benefit from these cell lines, as they address critical questions regarding protein degradation pathways and their implications in human health. Their ease of use in various experimental designs, combined with comprehensive documentation and support, ensures that scientists can swiftly integrate them into their workflows.
With years of experience in the development of high-quality genetic tools, our company is dedicated to empowering the scientific community with state-of-the-art products like UBR2 Gene Knockout Cell Lines, driving research forward and accelerating discoveries in molecular and cellular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.